ArticleBMC urology2019

Second-line treatment strategy for urothelial cancer patients who progress or are unfit for cisplatin therapy: a network meta-analysis.

Huitao Wang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.